Press releases
* (R) = Regulatory press releases
Jun 26, 2017
(R) Cantargia: Preclinical studies of IL1RAP and CAN04 in solid tumours presented at EACR-AACR-SIC in Florence
Jun 1, 2017
(R) Cantargia obtains patent approval in China for therapy against IL1RAP in acute lymphoblastic leukemia
May 19, 2017
(R) Cantargia strengthens organisation with CFO
May 8, 2017
(R) Cantargia’s product candidate CAN04 shows good safety properties in studies performed under GLP
Apr 5, 2017
(R) Cantargia receives an Intention to Grant notice in Europe for its CAN04 product candidate
Mar 15, 2017
